IDYA Overview
Upcoming Projects (IDYA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (IDYA)
-
Reviewing IDEAYA Biosciences' recent Phase 2 clinical trial evaluating darovasertib and crizotinib combination in metastatic uveal melanoma patients
Ticker: IDYA
Executed On: Apr 05, 2023 at 01:00 PM EDT -
A second look: Discussing recent advancements and use of synthetic lethality based cancer therapeutics and areas for future development.
Tickers: IDYA, MRK, AZN
Executed On: Mar 21, 2023 at 01:00 PM EDT -
Discussing recent advancements and use of synthetic lethality based cancer therapeutics and areas for future development.
Tickers: IDYA, AZN, MRK
Executed On: Mar 16, 2023 at 04:30 PM EDT -
A look at the interim results from the P2 trial evaluating darovasertib(IDE196) and crizotinib synthetic lethal combination in metastatic uveal melanoma patients
Tickers: IDYA, PFE, IMCR
Executed On: Nov 01, 2022 at 03:00 PM EDT
Upcoming & Overdue Catalysts (IDYA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (IDYA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
